Cleared Traditional

K111731 - MOLECULAR BREAST IMAGING SOFTWARE

K111731 is an FDA 510(k) clearance for MOLECULAR BREAST IMAGING SOFTWARE, manufactured by Gamma Medica-Ideas Incorporated. The device is a Class 2 Radiology device with product code LLZ cleared through the Traditional 510(k) pathway after a 87-day FDA review.

K111731 · Gamma Medica-Ideas Incorporated · Radiology device
Download Printable Device Report (PDF) Official FDA 510(k) Summary (PDF)
Optimized for regulatory review, auditing and printing
Sep 2011
Decision
87d
Days
Class 2
Risk

K111731 is an FDA 510(k) clearance for the MOLECULAR BREAST IMAGING SOFTWARE. Classified as System, Image Processing, Radiological within the LLZ classification (a category encompassing advanced image processing and PACS-adjacent software), Class II - Special Controls.

Submitted by Gamma Medica-Ideas Incorporated (Sunnyvale, US). The FDA issued a Cleared decision on September 15, 2011 after a review of 87 days - a notably fast clearance cycle.

This device falls under the Radiology FDA review panel, regulated under 21 CFR 892.2050 - the FDA radiology and imaging software oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Incremental AI imaging tool. Moderate equivalence dependency. Overall, this clearance reflects a predicate-aligned approval typical of modern AI radiology extensions - not a novel clinical breakthrough, but a validated iteration within an established regulatory category.

FDA 510(k) Submission Details - K111731

510(k) Number K111731 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received June 20, 2011
Decision Date September 15, 2011
Days to Decision 87 days
Submission Type Traditional
Review Panel Radiology (RA)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
20d faster than avg
Panel avg: 107d · This submission: 87d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

LLZ Device Classification - Class 2, Special Controls

Product Code LLZ System, Image Processing, Radiological
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 892.2050
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Radiology devices follow this clearance model.

Regulatory Peers - LLZ System, Image Processing, Radiological

All 2270
Devices cleared under the same product code (LLZ) and FDA review panel - the closest regulatory comparables to K111731.
R4 ACERT ULTRASOUND REPORTING SYSTEM
K101898 · R4, LLC · Sep 2011
FEEL-DRCS
K110033 · Imfou Co., Ltd. · Sep 2011
ASTRA
K111694 · Candelis, Inc. · Sep 2011
XELIS CARDIAC
K111660 · Infinitt Co., Ltd. · Sep 2011
RESOLUTIONMD MOBILE MODEL RMB-MOB-2X
K111346 · Calgary Scientific, Inc. · Sep 2011
XELIS FUSION
K111613 · Infinitt Co., Ltd. · Sep 2011
K111731 · MOLECULAR BREAST IMAGING SOFTWARE
Download PDF FDA Summary Gamma Medica-Ideas In…